Prognostic significance of the expression of GFRα1, GFRα3 and Syndecan-3, Proteins binding ARTEMIN, In mammary carcinoma

by Wu, Z.-S., Pandey, V., Wu, W.-Y., Ye, S., Zhu, T., Lobie, P.E.
Published 2014

Mechanistic Involvement of Long Non-Coding RNAs in Oncotherapeutics Resistance in Triple-Negative Breast Cancer

by Kansara, S., Pandey, V., Lobie, P.E., Sethi, G., Garg, M., Pandey, A.K.
Published 2021

Recent developments in machine learning and flyrock prediction

by Bhatawdekar, Ramesh Murlidhar, Kainthola, Ashutosh, Pandey, V. H. R., Nath, Singh Trilok, Mohamad, Edy Tonnizam
Published 2022

Trefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma

by Pandey, V, Wu, Z.-S, Zhang, M, Li, R, Zhang, J, Zhu, T, Lobie, P.E
Published 2020

Trefoil factor-3 (TFF3) stimulates de novo angiogenesis in mammary carcinoma both directly and indirectly via IL-8/CXCR2

by Lau W.-H., Pandey V., Kong X., Wang X.-N., Wu Z., Zhu T., Lobie P.E.
Published 2018

ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma

by Banerjee, A., Wu, Z.-S., Qian, P., Kang, J., Pandey, V., Liu, D.-X., Zhu, T., Lobie, P.E.
Published 2014

Autocrine human growth hormone promotes invasive and cancer stem cell-like behavior of hepatocellular carcinoma cells by STAT3 dependent inhibition of CLAUDIN-1 expression

by Chen Y.-J., You M.-L., Chong Q.-Y., Pandey V., Zhuang Q.-S., Liu D.-X., Ma L., Zhu T., Lobie P.E.
Published 2020

Expression of two non-mutated genetic elements is sufficient to stimulate oncogenic transformation of human mammary epithelial cells

by Pandey, V, Zhang, M, You, M, Zhang, W, Chen, R, Zhang, W, Ma, L, Wu, Z.-S, Zhu, T, Xu, X.Q, Lobie, P.E
Published 2020

Trefoil factor 1 suppression of E-CADHERIN enhances prostate carcinoma cell invasiveness and metastasis

by Bougen, N.M., Amiry, N., Yuan, Y., Kong, X.J., Pandey, V., Vidal, L.J.P., Perry, J.K., Zhu, T., Lobie, P.E.
Published 2014

Loss of SNAIL regulated miR-128-2 on chromosome 3p22.3 targets multiple stem cell factors to promote transformation of mammary epithelial cells

by Qian, P., Banerjee, A., Wu, Z.-S., Zhang, X., Wang, H., Pandey, V., Zhang, W.-J., Lv, X.-F., Tan, S., Lobie, P.E., Zhu, T.
Published 2014

STAT3α is oncogenic for endometrial carcinoma cells and mediates the oncogenic effects of autocrine human growth hormone

by Tang, J.-Z., Kong, X.-J., Banerjee, A., Muniraj, N., Pandey, V., Steiner, M., Perry, J.K., Zhu, T., Liu, D.-X., Lobie, P.E.
Published 2014

Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent

by You, M.-L, Chen, Y.-J, Chong, Q.-Y, Wu, M.-M, Pandey, V, Chen, R.-M, Liu, L, Ma, L, Wu, Z.-S, Zhu, T, Lobie, P.E
Published 2020

Pharmacological inhibition of TFF3 enhances sensitivity of CMS4 colorectal carcinoma to 5-fluorouracil through inhibition of p44/42 MAPK

by Chen, R.-M., Chiou, Y.-S., Chong, Q.-Y., Poh, H.-M., Tan, T.-Z., Zhang, M.-Y., Ma, L., Zhu, T., Pandey, V., Salundi, B., Prem Kumar, A., Lobie, P.E.
Published 2021

Hypomethylation associated enhanced transcription of trefoil factor-3 mediates tamoxifen-stimulated oncogenicity of ER+ endometrial carcinoma cells

by Pandey, V, Zhang, M, Chong, Q.-Y, You, M, Raquib, A.R, Pandey, A.K, Liu, D.-X, Liu, L, Ma, L, Jha, S, Wu, Z.-S, Zhu, T, Lobie, P.E
Published 2020

Autocrine hGH stimulates oncogenicity, epithelial-mesenchymal transition and cancer stem cell-like behavior in human colorectal carcinoma

by Wang J.-J., Chong Q.-Y., Sun X.-B., You M.-L., Pandey V., Chen Y.-J., Zhuang Q.-S., Liu D.-X., Ma L., Wu Z.-S., Zhu T., Lobie P.E.
Published 2020

Human growth hormone and human prolactin function as autocrine/paracrine promoters of progression of hepatocellular carcinoma

by Kong, X, Wu, W, Yuan, Y, Pandey, V, Wu, Z, Lu, X, Zhang, W, Chen, Y, Wu, M, Zhang, M, Li, G, Tan, S, Qian, P, Perry, J.K, Lobie, P.E, Zhu, T
Published 2020

Annexin-A1 regulates MicroRNA-26b? and MicroRNA-562 to directly target NF-?B and angiogenesis in breast cancer cells

by Anbalagan D., Yap G., Yuan Y., Pandey V.K., Lau W.H., Arora S., Bist P., Wong J.S.B., Sethi G., Nissom P.M., Lobie P.E., Lim L.H.K., Li J.
Published 2018

A novel small-molecule inhibitor of trefoil factor 3 (TFF3) potentiates MEK1/2 inhibition in lung adenocarcinoma

by Zhang, M., Wang, B., Chong, Q.-Y., Pandey, V., Guo, Z., Chen, R.-M., Wang, L., Wang, Y., Ma, L., Kumar, A.P., Zhu, T., Wu, Z.-S., Yin, Z., Basappa, Goh, B.-C., Lobie, P.E.
Published 2021

Inhibition of TFF3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinoma

by Poh, H.M., Chiou, Y.S., Chong, Q.Y., Chen, R.-M., Rangappa, K.S., Ma, L., Zhu, T., Kumar, A.P., Pandey, V., Basappa, Department of Studies in Organic Chemistry, University of Mysore, Mysore, 570005, India., Lee, S.-C., Lobie, P.E.
Published 2021

Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma

by Chong, Q.-Y, You, M.-L, Pandey, V, Banerjee, A, Chen, Y.-J, Poh, H.-M, Zhang, M, Ma, L, Zhu, T, Basappa, Laboratory of Chemical Biology, Department of Chemistry, Bangalore University, Central College Campus, Bangalore, India, Liu, L, Lobie, P.E
Published 2020